1. Home
  2. MRAM vs CADL Comparison

MRAM vs CADL Comparison

Compare MRAM & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Everspin Technologies Inc.

MRAM

Everspin Technologies Inc.

HOLD

Current Price

$10.58

Market Cap

300.6M

Sector

Technology

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$5.69

Market Cap

320.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRAM
CADL
Founded
2008
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
300.6M
320.6M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
MRAM
CADL
Price
$10.58
$5.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$10.50
$19.43
AVG Volume (30 Days)
1.2M
721.4K
Earning Date
02-25-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$53,642,000.00
N/A
Revenue This Year
$11.00
N/A
Revenue Next Year
$9.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.34
$4.25
52 Week High
$17.24
$13.68

Technical Indicators

Market Signals
Indicator
MRAM
CADL
Relative Strength Index (RSI) 42.50 47.85
Support Level $12.43 $5.68
Resistance Level $15.93 $6.11
Average True Range (ATR) 1.75 0.35
MACD -0.36 -0.06
Stochastic Oscillator 6.66 9.47

Price Performance

Historical Comparison
MRAM
CADL

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: